No abstract is available for this article. mehr
Um alle Funktionen dieser Seite zu nutzen, aktivieren Sie bitte die Cookies in Ihrem Browser.
Mit einem my.bionity.com-Account haben Sie immer alles im Überblick - und können sich Ihre eigene Website und Ihren individuellen Newsletter konfigurieren.
A series of benzaldehyde and salicylaldehyde‐S‐benzylisothiosemicarbazones was synthesized and tested against 12 different strains of mycobacteria, Gram‐positive and Gram‐negative bacteria, and the significant selectivity toward mycobacteria was proved. Twenty‐eight derivatives were evaluated for the inhibition of isocitrate lyase, which is a key enzyme of the glyoxylate cycle necessary for latent tuberculosis infection, and their iron‐chelating properties were investigated. Two derivatives, 5‐bromosalicylaldehyde‐S‐(4‐fluorobenzyl)‐isothiosemicarbazone and salicylaldehyde‐S‐(4‐bromobenzyl)‐isothiosemicarbazone, influenced the isocitrate lyase activity and caused a better inhibition at 10 μmol/L than 3‐nitropropionic acid, a standard inhibitor. The compounds were also found to act as exogenous chelators of iron, which is an obligate cofactor for many mycobacterial enzymes. Due to their low cytotoxicity, together with the activity against isocitrate lyase and the ability to sequester iron ions, the compounds belong to potential antibiotics with the main effect on mycobacteria.
A series of benzaldehyde and salicylaldehyde‐S‐benzylisothiosemicarbazones was synthesized and tested for antimycobacterial selectivity. Twenty‐eight derivatives were evaluated for the inhibition of isocitrate lyase, a key enzyme of the glyoxylate cycle necessary for latent tuberculosis infection. The compounds show promising activity as potential antibiotics with the main effect on mycobacteria.
|Autoren:||Eva Novotná, Karel Waisser, Jiří Kuneš, Karel Palát, Lenka Skálová, Barbora Szotáková, Vladimír Buchta, Jiřina Stolaříková, Vít Ulmann, Marcela Pávová, Jan Weber, Jitka Komrsková, Pavlína Hašková, Ivan Vokřál, Vladimír Wsól|
|Journal:||Archiv der Pharmazie|
Abstract The single radial immunodiffusion assay has been the accepted method for determining the potency of inactivated influenza vaccines since 1978. The world‐wide adoption of this assay for vaccine standardisation was facilitated through collaborative studies that demonstrated a high ... mehr
Abstract Background Whether morbidity from the 1918‐19 influenza pandemic discriminated by socioeconomic status has remained a subject of debate for 100 years. In lack of data to study this issue recent literature have hypothesized that morbidity was “socially neutral”. Objectives ... mehr